-transparent.png){kind=logo}
Human secretory leucocyte proteinase inhibitor (SLPI) is a low-molecular weight, acid-stable inhibitor of polymorph-nuclear granulocyte elastase and cathepsin G. Previous reports have demonstrated the existence of SLPI in the respiratory tract, salivary glands and cervical mucosa. Positive staining for SLPI using immunohistochemical techniques has been reported in serous glands in nasal mucosa. We now confirm this observation and show, using in situ hybridization, that the pattern of expression of mRNA corresponds to the distribution of the encoded protein, SLPI. This, together with the high concentration of SLPI in nasal secretions, confirms the hypothesis of a local production of SLPI in the mucous membranes.
U Westin, and
U Fryksmark, and
A Polling, and
K Ohlsson
December 2001,
Mediators of inflammation,
U Westin, and
U Fryksmark, and
A Polling, and
K Ohlsson
September 1997,
Biological chemistry,
U Westin, and
U Fryksmark, and
A Polling, and
K Ohlsson
May 1992,
The European respiratory journal,
U Westin, and
U Fryksmark, and
A Polling, and
K Ohlsson
February 1994,
Clinica chimica acta; international journal of clinical chemistry,
U Westin, and
U Fryksmark, and
A Polling, and
K Ohlsson
October 1992,
Gastroenterologia Japonica,
U Westin, and
U Fryksmark, and
A Polling, and
K Ohlsson
December 1993,
European journal of biochemistry,
U Westin, and
U Fryksmark, and
A Polling, and
K Ohlsson
September 2014,
Archives of oral biology,
U Westin, and
U Fryksmark, and
A Polling, and
K Ohlsson
March 1989,
Biochimica et biophysica acta,
U Westin, and
U Fryksmark, and
A Polling, and
K Ohlsson
September 1998,
Rhinology,
U Westin, and
U Fryksmark, and
A Polling, and
K Ohlsson
March 1992,
Acta paediatrica (Oslo, Norway : 1992),
